6.57
price up icon0.46%   0.03
after-market Handel nachbörslich: 6.44 -0.13 -1.98%
loading
Schlusskurs vom Vortag:
$6.54
Offen:
$6.47
24-Stunden-Volumen:
65,219
Relative Volume:
0.33
Marktkapitalisierung:
$52.32M
Einnahmen:
$49.09M
Nettoeinkommen (Verlust:
$-52.15M
KGV:
-10.11
EPS:
-0.65
Netto-Cashflow:
$-45.93M
1W Leistung:
+2.18%
1M Leistung:
-12.98%
6M Leistung:
-38.53%
1J Leistung:
-80.21%
1-Tages-Spanne:
Value
$6.33
$6.94
1-Wochen-Bereich:
Value
$6.22
$7.06
52-Wochen-Spanne:
Value
$3.436
$34.39

Biodesix Inc Stock (BDSX) Company Profile

Name
Firmenname
Biodesix Inc
Name
Telefon
303-417-0500
Name
Adresse
919 WEST DILLON ROAD, LOUISVILLE
Name
Mitarbeiter
273
Name
Twitter
Name
Nächster Verdiensttermin
2025-03-03
Name
Neueste SEC-Einreichungen
Name
BDSX's Discussions on Twitter

Vergleichen Sie BDSX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Diagnostics & Research icon
BDSX
Biodesix Inc
6.57 52.32M 49.09M -52.15M -45.93M -0.65
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
556.22 210.82B 43.74B 6.59B 6.11B 17.30
Diagnostics & Research icon
DHR
Danaher Corp
215.05 151.17B 24.27B 3.50B 5.02B 4.8589
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
628.54 50.22B 4.04B 985.66M 774.34M 12.01
Diagnostics & Research icon
A
Agilent Technologies Inc
143.36 40.60B 6.79B 1.22B 1.09B 4.2644
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
216.47 37.10B 15.70B 1.24B 2.01B 6.9036

Biodesix Inc Stock (BDSX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-05-14 Herabstufung William Blair Outperform → Mkt Perform
2024-09-16 Eingeleitet Scotiabank Sector Outperform
2024-07-26 Eingeleitet Craig Hallum Buy
2024-05-13 Eingeleitet TD Cowen Buy
2024-05-03 Eingeleitet Lake Street Buy
2021-11-17 Herabstufung Morgan Stanley Overweight → Equal-Weight
2020-11-23 Eingeleitet BTIG Research Buy
2020-11-23 Eingeleitet Canaccord Genuity Buy
2020-11-23 Eingeleitet Morgan Stanley Overweight
2020-11-23 Eingeleitet William Blair Outperform
Alle ansehen

Biodesix Inc Aktie (BDSX) Neueste Nachrichten

pulisher
07:45 AM

Biodesix Inc. recovery potential after sell off2025 Earnings Surprises & Stepwise Entry and Exit Trade Signals - newser.com

07:45 AM
pulisher
06:20 AM

Biodesix to Showcase R&D Innovations and Collaborations at 2025 AMP Annual Meeting in Boston - Quiver Quantitative

06:20 AM
pulisher
06:17 AM

Biodesix to Share its R&D Roadmap during its Corporate Day Presentation at AMP Annual Meeting - MarketScreener

06:17 AM
pulisher
06:17 AM

Biodesix (NASDAQ: BDSX) plans AMP 2025 workshop on NGS, ddPCR and mass spec advances - Stock Titan

06:17 AM
pulisher
06:04 AM

Institutional scanner results for Biodesix Inc.July 2025 Trade Ideas & Free Risk Controlled Daily Trade Plans - newser.com

06:04 AM
pulisher
05:15 AM

Will breakout in Biodesix Inc. lead to full recoveryJuly 2025 Selloffs & Weekly Momentum Picks - newser.com

05:15 AM
pulisher
04:01 AM

Is Biodesix Inc. stock a good choice for value investorsTreasury Yields & Stepwise Trade Signal Guides - newser.com

04:01 AM
pulisher
02:37 AM

Can Biodesix Inc. stock rebound after recent weaknessBear Alert & Detailed Earnings Play Strategies - newser.com

02:37 AM
pulisher
02:24 AM

Technical signs of recovery in Biodesix Inc.2025 Analyst Calls & Entry Point Strategy Guides - newser.com

02:24 AM
pulisher
Oct 29, 2025

Order flow analysis tools used on Biodesix Inc.Forecast Cut & Growth-Oriented Investment Plans - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

Biodesix CEO rings Nasdaq’s closing bell - BizWest

Oct 29, 2025
pulisher
Oct 29, 2025

Louisville company rings Nasdaq bell after regaining listing compliance - The Business Journals

Oct 29, 2025
pulisher
Oct 29, 2025

Can Biodesix Inc. stock outperform in 2025 bull marketWeekly Investment Summary & Fast Exit and Entry Trade Guides - newser.com

Oct 29, 2025
pulisher
Oct 28, 2025

Will Biodesix Inc. stock reach all time highs in 2025July 2025 Price Swings & Daily Growth Stock Investment Tips - Fundação Cultural do Pará

Oct 28, 2025
pulisher
Oct 28, 2025

Biodesix, Inc. Rings the Closing Bell - Nasdaq

Oct 28, 2025
pulisher
Oct 28, 2025

Is Biodesix Inc. stock a bargain at current levelsPortfolio Risk Summary & High Yield Equity Trading Tips - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

How risky is Biodesix Inc. stock nowPortfolio Update Report & Growth Oriented Trading Recommendations - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Best data tools to analyze Biodesix Inc. stockGold Moves & Safe Capital Investment Plans - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Is Biodesix Inc. a candidate for recovery playJuly 2025 Selloffs & Risk Managed Investment Signals - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Regression analysis insights on Biodesix Inc. performancePortfolio Update Report & Expert Curated Trade Ideas - newser.com

Oct 28, 2025
pulisher
Oct 27, 2025

Published on: 2025-10-27 22:09:06 - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Published on: 2025-10-27 19:23:02 - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Biodesix Expands Bio-Rad Partnership in Cancer Diagnostics - Technology Networks

Oct 27, 2025
pulisher
Oct 26, 2025

How to manage a losing position in Biodesix Inc.2025 Buyback Activity & Free Safe Capital Growth Stock Tips - newser.com

Oct 26, 2025

Finanzdaten der Biodesix Inc-Aktie (BDSX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Biodesix Inc-Aktie (BDSX) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
SCHULER JACK W
Director
Sep 17 '25
Buy
6.04
15,317
92,571
1,235,644
SCHULER JACK W
Director
Sep 18 '25
Buy
6.17
3,056
18,854
1,238,700
SCHULER JACK W
Director
Aug 29 '25
Buy
0.43
3,488,372
1,500,000
24,406,546
Cowie Robin Harper
CFO, Sec'y & Treasurer
Aug 13 '25
Sale
0.42
988
411
250,794
Hutton Scott
President & CEO
Aug 13 '25
Sale
0.42
3,772
1,570
728,824
O'Kane Kieran
Chief Commercial Officer
Aug 13 '25
Sale
0.42
476
198
140,065
Pestano Gary Anthony
Chief Development Officer
Aug 13 '25
Sale
0.42
442
184
157,878
Vazquez Chris
Chief Accounting Officer
Aug 13 '25
Sale
0.42
228
95
18,375
SCHULER JACK W
Director
May 16 '25
Buy
0.27
4,000,000
1,070,000
20,194,935
SCHULER JACK W
Director
May 19 '25
Buy
0.34
723,239
246,624
20,918,174
diagnostics_research DGX
$175.75
price up icon 0.55%
diagnostics_research WAT
$342.90
price down icon 0.17%
diagnostics_research LH
$252.33
price up icon 1.69%
$193.22
price up icon 0.21%
diagnostics_research MTD
$1,377.01
price down icon 1.23%
diagnostics_research IQV
$216.47
price down icon 0.62%
Kapitalisierung:     |  Volumen (24h):